Skip to main content
Figure 2 | World Journal of Surgical Oncology

Figure 2

From: Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases

Figure 2

Overall survival between the USC and PTR groups. Median survival times were 13.4 and 23.9 months in USC and PTR, respectively, and overall survival was not significantly different in the two groups. USC: up-front systemic chemotherapy group. PTR: primary tumor resection group. HR: hazard ratio. CI: confidence interval.

Back to article page